Related Experiment Video
Updated: Jul 13, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
Ventricular tachycardia after administration of sildenafil citrate: a case report
Jeppe G Rasmussen1, Egon Toft, Ole Frøbert
1Department of Cardiology, Center for Cardiovascular Research, Aalborg Hospital, Aarhus University Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark. jgr1@dadlnet.dk.
Background:
It has not previously been reported that sildenafil citrate causes malignant arrhythmias in humans.
Case Presentation:
A 41-year-old man developed sustained ventricular tachycardia following sildenafil citrate administration.
Conclusion:
It cannot be dismissed that this patient experienced ventricular tachycardia as an adverse effect of sildenafil citrate administration.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Dysrhythmias II: Classification of Tachyarrhythmias
Coronary Artery Disease III: Clinical Manifestations
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
